SSA
MRNA icon

Schonfeld Strategic Advisors’s Moderna MRNA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,691
Closed -$797K – 2852
2026
Q1 		$797K Sell
15,691
-6,086
-28% -$284K 0.01% 1199
2025
Q4 		$642K Buy
+21,777
New +$592K ﹤0.01% 1293
2025
Q3 		– Sell
-76,897
Closed -$2.12M – 2427
2025
Q2 		$2.12M Buy
76,897
+54,647
+246% +$1.44M 0.01% 948
2025
Q1 		$631K Sell
22,250
-45,542
-67% -$1.62M ﹤0.01% 1484
2024
Q4 		$2.82M Buy
67,792
+49,953
+280% +$2.39M 0.02% 701
2024
Q3 		$1.19M Sell
17,839
-120,723
-87% -$11.1M 0.01% 1103
2024
Q2 		$16.5M Buy
138,562
+125,877
+992% +$15.9M 0.11% 210
2024
Q1 		$1.35M Sell
12,685
-2,011
-14% -$203K 0.01% 1115
2023
Q4 		$1.46M Sell
14,696
-3,323
-18% -$279K 0.01% 909
2023
Q3 		$1.86M Buy
+18,019
New +$2.01M 0.01% 850
2023
Q1 		– Sell
-39,264
Closed -$7.05M – 2431
2022
Q4 		$7.05M Sell
39,264
-12,623
-24% -$2.06M 0.06% 390
2022
Q3 		$6.14M Buy
51,887
+43,538
+521% +$6.61M 0.05% 458
2022
Q2 		$1.19M Sell
8,349
-2,155
-21% -$308K 0.01% 940
2022
Q1 		$1.81M Buy
10,504
+8,838
+530% +$1.49M 0.02% 778
2021
Q4 		$423K Sell
1,666
-3,034
-65% -$887K ﹤0.01% 1347
2021
Q3 		$1.81M Sell
4,700
-30,352
-87% -$11.2M 0.02% 749
2021
Q2 		$8.24M Buy
+35,052
New +$6.26M 0.09% 328
2021
Q1 		– Sell
-2,410
Closed -$252K – 2018
2020
Q4 		$252K Buy
+2,410
New +$244K ﹤0.01% 1264
2020
Q2 		– Sell
-7,436
Closed -$223K – 1441
2020
Q1 		$223K Buy
+7,436
New +$171K 0.01% 872

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Schonfeld Strategic Advisors's MRNA Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of Moderna (MRNA) in Q2 2026, closing a stake of 15,691 shares — an estimated $797K sold.

Schonfeld Strategic Advisors first reported a position in MRNA in Q1 2020 and held it in 19 quarters. The position peaked at $16.5M in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 15,691 Moderna shares in Q2 2026, an estimated $797K.
  • Schonfeld Strategic Advisors first reported a position in Moderna in Q1 2020 and held it in 19 quarters.
  • Schonfeld Strategic Advisors's Moderna position peaked at $16.5M in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.